Atlas Trials

Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Clinical trial NCT03228186 · TERMINATED

Trial details

NCT number
NCT03228186
Sponsor
University of Michigan Rogel Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2018-03-05
Primary completion
2021-11-04
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.